Douglas Berger Psychiatrist Tokyo

Douglas Berger psychiatrist Tokyo is an American board certified psychiatrist and is the Director of the Tokyo Meguro Counseling Center. He’s also fully bilingual in Japanese and English. Dr. Berger received his M.D. and psychiatry training from New York Medical College, and his Ph.D. from the Department of Psychosomatic Medicine at the Tokyo University School of Medicine. He speaks native-level Japanese. Dr. Berger utilizes a variety of approaches to psychiatry, which you can find here, and on the Tokyo Meguro Counseling Center’s home page.

Dr. Berger can be contacted by phone: 03-3716-6624 (+81-3-3716-6624 from outside of Japan). Please use this form if you wish to contact Dr. Douglas Berger psychiatrist in Tokyo.

> Dr. Berger’s credentials & publications can be found on this page.
> Click here for more information about his practice
> To read reviews from some of Dr. Berger’s patients.

Tokyo Counseling Service: Catagorizing Personality, not simple. https://t.co/UhyfW2fHb9 @YouTubeさんから

The no of subjects with brain changes on Mindfulness is not reported: https://t.co/CC4HlhldEi. If only a few subjects had large changes, what does that really say? It is also not clear what the size of this change means clinically or physiologically. Us: https://t.co/WLIjKdXqXL

Brain changes in Mindfulness Based therapy was unblinded with only 16 subjects: https://t.co/CC4HlhldEi. If you look at many brain sections you may find something by chance, you need to half your p value for each section looked at, not done here. Us: https://t.co/kbQF1wSzGN

Tokyo Counseling Service on ADHD https://t.co/LPwy8DzMbB @YouTubeさんから

Antidepressants show efficacy under double blind vs blind placebo because blinding filters out hope and expectation. Neither randomization nor blind assessment can make up for the loss of control from no-blind, no placebo conditions. Us: https://t.co/tReJReVhnP

Blind placebo pills give 30% improvement in depression. In depression drug trials, “non-inferiority” is very easily obtained as everyone responds to the placebo effect. Superiority studies have a higher statistical hurdle than non-inferiority studies. Us: https://t.co/CcbDgs5z45.

Medication vs psychotherapy isn't valid in a clinical trial because you can't double blind all the arms. Its uncontrolled clinical data, endpoints are subjective, and medications require double blinding or blind placebo: https://t.co/WLIjKdXqXL.

Clinical trial of mindfulness therapy (MBT) could be placebo: https://t.co/KNYN1UWrWl. Unblinded study w/no blind placebo. There is no MBT (or CBT, DBT, or other psychotherapy) outcome study that is single or double blind, nor one with a blind placebo. Us: https://t.co/WLIjKdXqXL

Load More...

Counseling Tokyo: to take money from patients for an unproven activity? https://t.co/Hpqw4c2xBN

Tokyo Counseling Service: Catagorizing personality is neither simple nor appropriate. https://t.co/mONoUMDt2X

Douglas Berger Tokyo psychiatrist: brain changes on Mindfulness; subject no and size isn't clear https://t.co/ymXnvrHKzh

Douglas Berger Tokyo psychiatrist: bridge for brain changes seen in mindfulness & efficacy for psychiatric illness https://t.co/K6k7BCrQt4

There is no clear bridge for brain changes seen in mindfulness & efficacy for psychiatric illness: https://t.co/ASq8y9Jzo5. The subjects are all healthy people, making the connection to various psychiatric illness speculation. Us: https://t.co/2cyfo9FRgl

Douglas Berger Tokyo psychiatrist: Brain changes in Mindfulness Based therapy https://t.co/zpuzl9UBif

Douglas Berger Tokyo psychiatrist: Many therapy studies call themselves, “single-blind” https://t.co/uKasdYEwnY

Many therapy studies call themselves, “single-blind”, however, this when the subject is blind, not when assessors are blind. “Single-blind” is misleading the reader that there is some control of bias when there is not. Us: https://t.co/sooQBqR2nb.

Load More...

The Moffic Meditation article rationalizes to take money from patients for an unproven activity: https://t.co/PoSdPVSbWO. Using Insurance for unproven activities can whittle benefits & diverts therapies proven in double-blind placebo trials. Us: https://t.co/DnZXryAivC

Blind ratings in a psychotherapy study are mistakenly called “single-blind”. Ratings in a clinical trial only record reports from the subject and treater system. Any bias in subjects can add up with a large N to obtain erroneous "efficacy". Us: https://t.co/HAmnqhjQXK .

カウンセリング東京のYouTube教育ビデオの日本語プレーリストができました(Counseling Tokyo's Japanese YouTube educational video play list): https://t.co/3dzqU6A3pi; https://t.co/rQgawRYyGW; https://t.co/hPsSSl9Z6d; https://t.co/bJhHCQlcqS.

"Cardiac syndrome X" is angina without clogged arties: https://t.co/50ZTNfCT7P. Usually in women, microvascular disease is behind the ventricles not filling properly, causing heart failure with preserved ejection fraction. Us: https://t.co/Fy4b1Rw61Q

Babies’ first solid food found to have at least one dangerous heavy metal in every product: https://t.co/Fe4hsdOsfQ. 15/50 products contained enough to pose health risks. Us: https://t.co/gR24sehgqG

Various actions can change the function of the brain. Brain changes are not necessarily indicative of an effect of a specific psychotherapy; visual-motor training or meditation may also make brain changes (if we assume unblinded studies are valid). Us: https://t.co/dxTjUotW9q

Dr. Cynthia Geppert should acknowledge that some end-stage persons should be helped to end their lives: https://t.co/ByrcXu6e8p. The article has a conservative/religious agenda-Dr. Geppert had a PhD in Religious Ethics from a church-sponsored school. Us: https://t.co/tQq75VPSbJ.

"152k ER visits for benzos, 28% hospitalized, vs 22k ER visits for MDMA, 9.5& hospitalized": https://t.co/PTXTC20Eng. But this isn't a valid comparison: 5% of US adults take benzos every year!!, many along with other drugs. Us: https://t.co/rqep1aL9B8

Load More...

Save

Save